Form 8-K BIOGEN INC. For: Apr 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Biogen expects $34 million charge in first quarter 2026
April 6, 2026 6:36 AM EDTBiogen Inc. (NASDAQ: BIIB) announced it expects to record approximately $34 million in acquired in-process research and development, upfront and milestone expenses on a pre-tax basis during the first quarter of 2026.
The charge is projected to impact both GAAP and non-GAAP net income per... More
